rbd003

Robert B. Den, MD

Contact Dr. Den

111 South 11th Street
Room G-301, Bodine Center
Philadelphia, PA 19107

(215) 955-6702
(215) 955-0412 fax

Most Recent Peer-reviewed Publications

  1. Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer
  2. Current perspectives on bone metastases in castrate-resistant prostate cancer
  3. Utilizing 10-Year Results From the American Board of Radiology Clinical Examination to Identify Areas for Programmatic Improvement
  4. Development and validation of a novel integrated clinical-genomic risk group classification for localized prostate cancer
  5. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study
  6. Role of genetic testing for inherited prostate cancer risk: Philadelphia prostate cancer consensus conference 2017
  7. Process Mapping and Time Study to Improve Efficiency of New Procedure Implementation for High-Dose Rate Prostate Brachytherapy
  8. Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities
  9. Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer
  10. TOP2A and EZH2 provide early detection of an aggressive prostate cancer subgroup
  11. Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomy
  12. The role of genomic techniques in predicting response to radiation therapy
  13. Increasing faculty participation in resident education and providing cost-effective self-assessment module credit to faculty through resident-generated didactics
  14. Genomic classifier augments the role of pathological features in identifying optimal candidates for adjuvant radiation therapy in patients with prostate cancer: Development and internal validation of a multivariable prognostic model
  15. Individual patient-level meta-Analysis of the performance of the decipher genomic classifier in high-risk men after prostatectomy to predict development of metastatic disease
  16. Transcriptome evaluation of the relation between body mass index and prostate cancer outcomes
  17. Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality
  18. Cost-effectiveness of the Decipher Genomic Classifier to Guide Individualized Decisions for Early Radiation Therapy After Prostatectomy for Prostate Cancer
  19. siRNA-Encapsulated Hybrid Nanoparticles Target Mutant K-ras and Inhibit Metastatic Tumor Burden in a Mouse Model of Lung Cancer
  20. RB loss promotes prostate cancer metastasis